PDCD1 and melanoma: Anti-PD-1 enhanced T-cell immunity during SARS-Cov-2 infection in patients with melanoma, increased expansion of TEM, and induced the appearance of activated CD38+HLA-DR+ TEM cells (26) of the same phenotype as in our study.